Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
"Precursor T-Cell Lymphoblastic Leukemia-Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.
| Descriptor ID |
D054218
|
| MeSH Number(s) |
C04.557.337.428.600.620 C15.604.515.560.600.620 C20.683.515.528.600.620
|
| Concept/Terms |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T Cell Lymphoblastic Leukemia Lymphoma
- Leukemia, Lymphoblastic, Acute, T Cell
- Leukemia, Lymphoblastic, Acute, T-Cell
- Leukemia, Lymphocytic, Acute T Cell
- Leukemia, Lymphocytic, Acute, T-Cell
- Leukemia, T-Cell, Acute
- T-Lymphocytic Leukemia, Acute
- Acute T-Lymphocytic Leukemia
- Acute T-Lymphocytic Leukemias
- Leukemia, Acute T-Lymphocytic
- Leukemias, Acute T-Lymphocytic
- T Lymphocytic Leukemia, Acute
- T-Lymphocytic Leukemias, Acute
- Lymphoblastic Leukemia, Acute, T-Cell
- Lymphocytic Leukemia, T Cell, Acute
- Lymphocytic Leukemia, T-Cell, Acute
- Precursor T-Cell Lymphoblastic Leukemia
- Precursor T Cell Lymphoblastic Leukemia
- Precursor T-Cell Lymphoblastic Lymphoma
- Precursor T Cell Lymphoblastic Lymphoma
- T-ALL
- T-Cell Leukemia, Acute
- Acute T-Cell Leukemia
- Acute T-Cell Leukemias
- Leukemia, Acute T-Cell
- Leukemias, Acute T-Cell
- T Cell Leukemia, Acute
- T-Cell Leukemias, Acute
- T-Cell Acute Lymphocytic Leukemia
- Lymphoblastic Leukemia, Acute, T Cell
|
Below are MeSH descriptors whose meaning is more general than "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma".
Below are MeSH descriptors whose meaning is more specific than "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma".
This graph shows the total number of publications written about "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma" by people in this website by year, and whether "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 5 | 0 | 5 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 3 | 4 |
| 2012 | 3 | 0 | 3 |
| 2013 | 6 | 2 | 8 |
| 2014 | 3 | 1 | 4 |
| 2015 | 8 | 0 | 8 |
| 2016 | 7 | 0 | 7 |
| 2017 | 6 | 0 | 6 |
| 2018 | 10 | 1 | 11 |
| 2019 | 9 | 1 | 10 |
| 2020 | 9 | 0 | 9 |
| 2021 | 7 | 0 | 7 |
| 2022 | 12 | 0 | 12 |
| 2023 | 9 | 0 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma" by people in Profiles.
-
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study. Blood. 2023 12 14; 142(24):2069-2078.
-
DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia. Blood Adv. 2023 11 14; 7(21):6685-6701.
-
Integrin signaling is critical for myeloid-mediated support of T-cell acute lymphoblastic leukemia. Nat Commun. 2023 10 07; 14(1):6270.
-
BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia. Blood Adv. 2023 06 27; 7(12):2917-2923.
-
Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemia. Leukemia. 2023 06; 37(6):1194-1203.
-
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group report. Blood. 2023 04 13; 141(15):1802-1811.
-
Reverse Phase Protein Array Profiling Identifies Recurrent Protein Expression Patterns of DNA Damage-Related Proteins across Acute and Chronic Leukemia: Samples from Adults and the Children's Oncology Group. Int J Mol Sci. 2023 Mar 13; 24(6).
-
Antileukemic properties of the kinase inhibitor OTSSP167 in T-cell acute lymphoblastic leukemia. Blood Adv. 2023 02 14; 7(3):422-435.
-
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials. Lancet Haematol. 2023 Feb; 10(2):e129-e141.
-
Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignancies. Blood. 2022 12 22; 140(25):2684-2696.